OXYVITA

Oxyvita

Biotechnology, 108 World Trade Way, New Windsor, New York, 12553, United States, 11-50 Employees

oxyvita.us

  • LinkedIn

Who is OXYVITA

OXYVITA Inc. is a biotech company specializing in developing oxygen therapeutics and biomedical products utilizing our proprietary Zero-LinkTM hemoglobin polymerization process. OxyVita i...

Read More

map
  • 108 World Trade Way, New Windsor, New York, 12553, United States Headquarters: 108 World Trade Way, New Windsor, New York, 12553, United States
  • 2000 Date Founded: 2000
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from OXYVITA

OXYVITA Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding OXYVITA

Answer: OXYVITA's headquarters are located at 108 World Trade Way, New Windsor, New York, 12553, United States

Answer: OXYVITA's official website is https://oxyvita.us

Answer: OXYVITA's revenue is $1 Million to $5 Million

Answer: OXYVITA's SIC: 2834

Answer: OXYVITA has 11-50 employees

Answer: OXYVITA is in Biotechnology

Answer: OXYVITA contact info: Phone number: Website: https://oxyvita.us

Answer: OXYVITA Inc. is a biotech company specializing in developing oxygen therapeutics and biomedical products utilizing our proprietary Zero-LinkTM hemoglobin polymerization process. OxyVita is a polymerized stroma free hemoglobin. This polymeric hemoglobin solution, which is clinically useful as a blood substitute due to its oxygen carrying function, can dramatically reduce the need for blood donated by human donors and significantly reduce the risks associated with blood transfusions. OXYVITA Inc. is now significantly advanced in preclinical trials and will be seeking to progress into clinical trials upon FDA approval. Current fund raising is geared at funding the remaining animal trials and FDA application endeavors. We continue to supply product to independent researchers for further evaluation of potential applications. OXYVITA Inc. had recently entered into a CRADA (Collaborative Research and Development Agreement with the U.S. Navy.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access